Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:542-548
Published online before print August 11, 2008, doi: 10.1161/HYPERTENSIONAHA.108.114280
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
52/3/542    most recent
HYPERTENSIONAHA.108.114280v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dias-Peixoto, M. F.
Right arrow Articles by Guatimosim, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dias-Peixoto, M. F.
Right arrow Articles by Guatimosim, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Contractile function
Right arrow ACE/Angiotension receptors

(Hypertension. 2008;52:542.)
© 2008 American Heart Association, Inc.


Original Articles

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

Marco F. Dias-Peixoto; Robson A.S. Santos; Enéas R.M. Gomes; Márcia N.M. Alves; Pedro W.M. Almeida; Leonardo Greco; Mariana Rosa; Beatrix Fauler; Michael Bader; Natalia Alenina; Silvia Guatimosim

From the Department of Physiology and Biophysics (M.F.D.-P., R.A.S.S., E.R.M.G., M.N.M.A., P.W.M.A., L.G., M.R., B.F., S.G.), Federal University of Minas Gerais, Belo Horizonte, Brazil; and the Max-Delbrück Center for Molecular Medicine (M.B., N.A.), Berlin, Germany.

Correspondence to Silvia Guatimosim, Institute of Biological Sciences, Federal University of Minas Gerais, Av Antônio Carlos 6627, Belo Horizonte, MG-CEP 31270-901, Brazil. E-mail guatimosim{at}icb.ufmg.br

Recently there has been growing evidence suggesting that beneficial effects of angiotensin-(1-7) [Ang-(1-7)] in the heart are mediated by its receptor Mas. However, the signaling pathways involved in these effects in cardiomyocytes are unknown. Here, we investigated the involvement of the Ang-(1-7)/Mas axis in NO generation and Ca2+ handling in adult ventricular myocytes using a combination of molecular biology, intracellular Ca2+ imaging, and confocal microscopy. Acute Ang-(1-7) treatment (10 nmol/L) leads to NO production and activates endothelial NO synthase and Akt in cardiomyocytes. Ang-(1-7)–dependent NO raise was abolished by pretreatment with A-779 (1 µmol/L). To confirm that Ang-(1-7) action is mediated by Mas, we used cardiomyocytes isolated from Mas-deficient mice. In Mas-deficient cardiomyocytes, Ang-(1-7) failed to increase NO levels. Moreover, Mas-ablation was accompanied by significant alterations in the proteins involved in the regulation of endothelial NO synthase activity, indicating that endothelial NO synthase and its binding partners are important effectors of the Mas-mediated pathway in cardiomyocytes. We then investigated the role of the Ang-(1-7)/Mas axis on Ca2+ signaling. Cardiomyocytes treated with 10 nmol/L of Ang-(1-7) did not show changes in Ca2+-transient parameters such as peak Ca2+ transients and kinetics of decay. Nevertheless, cardiomyocytes from Mas-deficient mice presented reduced peak and slower [Ca2+]i transients when compared with wild-type cardiomyocytes. Lower Ca2+ ATPase of the sarcoplasmic reticulum expression levels accompanied the reduced Ca2+ transient in Mas-deficient cardiomyocytes. Therefore, chronic Mas-deficiency leads to impaired Ca2+ handling in cardiomyocytes. Collectively, these observations reveal a key role for the Ang-(1-7)/Mas axis as a modulator of cardiomyocyte function.


Key Words: ventricular cardiomyocytes • NO • Ca2+ transient • Ang-(1-7), Mas




This article has been cited by other articles:


Home page
Circ Heart FailHome page
Z. Kassiri, J. Zhong, D. Guo, R. Basu, X. Wang, P. P. Liu, J. W. Scholey, J. M. Penninger, and G. Y. Oudit
Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
Circ Heart Fail, September 1, 2009; 2(5): 446 - 455.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. N. Primola-Gomes, L. A. Campos, S. Lauton-Santos, C. H. Balthazar, S. Guatimosim, L. S. A. Capettini, V. S. Lemos, C. C. Coimbra, D. D. Soares, M. A. Carneiro-Junior, et al.
Exercise capacity is related to calcium transients in ventricular cardiomyocytes
J Appl Physiol, August 1, 2009; 107(2): 593 - 598.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Y. Oudit, Y. Imai, K. Kuba, J. W. Scholey, and J. M. Penninger
The role of ACE2 in pulmonary diseases--relevance for the nephrologist
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1362 - 1365.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. A. Stewart Jr, E. Lazartigues, and P. A. Lucchesi
The Angiotensin Converting Enzyme 2/Ang-(1-7) Axis in the Heart: A Role for Mas Communication?
Circ. Res., November 21, 2008; 103(11): 1197 - 1199.
[Full Text] [PDF]